1. Home
  2. JRVR vs XOMA Comparison

JRVR vs XOMA Comparison

Compare JRVR & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • XOMA
  • Stock Information
  • Founded
  • JRVR 2002
  • XOMA N/A
  • Country
  • JRVR Bermuda
  • XOMA United States
  • Employees
  • JRVR N/A
  • XOMA N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • JRVR Finance
  • XOMA Health Care
  • Exchange
  • JRVR Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • JRVR 297.7M
  • XOMA 298.3M
  • IPO Year
  • JRVR 2005
  • XOMA N/A
  • Fundamental
  • Price
  • JRVR $8.42
  • XOMA $28.72
  • Analyst Decision
  • JRVR Buy
  • XOMA Strong Buy
  • Analyst Count
  • JRVR 6
  • XOMA 2
  • Target Price
  • JRVR $12.40
  • XOMA $57.00
  • AVG Volume (30 Days)
  • JRVR 399.8K
  • XOMA 32.3K
  • Earning Date
  • JRVR 08-05-2024
  • XOMA 08-06-2024
  • Dividend Yield
  • JRVR 2.35%
  • XOMA N/A
  • EPS Growth
  • JRVR N/A
  • XOMA N/A
  • EPS
  • JRVR N/A
  • XOMA N/A
  • Revenue
  • JRVR $780,465,000.00
  • XOMA $5,811,000.00
  • Revenue This Year
  • JRVR N/A
  • XOMA $349.94
  • Revenue Next Year
  • JRVR $5.44
  • XOMA $28.50
  • P/E Ratio
  • JRVR N/A
  • XOMA N/A
  • Revenue Growth
  • JRVR 19.83
  • XOMA 73.10
  • 52 Week Low
  • JRVR $6.35
  • XOMA $13.48
  • 52 Week High
  • JRVR $19.07
  • XOMA $28.25
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 61.71
  • XOMA 64.67
  • Support Level
  • JRVR $7.84
  • XOMA $24.36
  • Resistance Level
  • JRVR $7.47
  • XOMA $27.05
  • Average True Range (ATR)
  • JRVR 0.42
  • XOMA 1.27
  • MACD
  • JRVR 0.14
  • XOMA 0.40
  • Stochastic Oscillator
  • JRVR 88.95
  • XOMA 95.66

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure. and the Corporate and other segment consists of the management and treasury activities of holding companies, equity compensation for the group.

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Share on Social Networks: